Loading clinical trials...
Loading clinical trials...
Solifenacin succinate as a tablet formulation is already on the market for the treatment of symptoms of overactive bladder in adults. For the use in children and adolescent patients a new formulation ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Astellas Pharma Europe B.V.
NCT07366918 · Urinary Bladder, Overactive
NCT05968885 · Urinary Bladder, Overactive, Urodynamics, and more
NCT06933407 · Urinary Incontinence, Urinary Incontinence, Stress, and more
NCT06336304 · Urinary Incontinence, Urinary Obstruction, and more
NCT01558856 · Urinary Bladder, Overactive
Site: 1006
Shreveport, Louisiana
Site: 1015
Albany, New York
Site: 3202
Antwerp
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions